Group intervention to reduce intimate partner abuse by men in substance use treatment

Conditions

Intimate partner abuse Mental and Behavioural Disorders Unspecified mental disorder

Gilchrist G, Potts L, Radcliffe P, Halliwell G, Dheensa S, Henderson J, Johnson A, Love B, Gilchrist E, Feder G, Parrott S, Li J, McMurran M, Kirkpatrick S, Stephens-Lewis D, Easton C, Berbary C, Landau S.

2021-05-2514 citations

10.1186/s12889-021-11012-3

A study protocol to assess the feasibility of conducting an evaluation trial of the ADVANCE integrated intervention to address both substance use and intimate partner abuse perpetration to men in substance use treatment.

Gilchrist G, Landau S, Radcliffe P, McMurran M, Feder G, Easton C, Parrott S, Kirkpatrick S, Henderson J, Potts L, Stephens-Lewis D, Johnson A, Love B, Halliwell G, Dheensa S, Berbary C, Li J, Strang J, Gilchrist E.

2020-05-114 citations

10.1186/s40814-020-00580-7

Interventions

Male participants will be allocated to the intervention group or TAU (ratio 1:1) by site via an independent online system based at the King’s Clinical Trials Unit (King’s CTU) based at King's College

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Male inclusion criteria: 1. Male participant has perpetrated abusive or violent behaviour towards a current or ex female partner in the last 12 months 2. Contact with current or ex female partner at least once in the past month - in person, or by phone/ text/ email/ social media 3. Plans to stay in current location for the next 6 months 4. Agrees to provide contact details of current and/or ex female partner 5. Ability to understand and communicate in English 6. Keyworker assesses as suitable to participate in the trial Female inclusion criteria: 1. Aged 18 years or older 2. Ability to understand and communicate in English

Exclusion criteria

Exclusion criteria: Male exclusion criteria: 1. Current or ex-partner is not female 2. Pending court case for IPV or pending child protection hearing 3. Current restraining order 4. Currently attending an intervention for IPV 5. Declines to provide contact details of current and/or ex female partner Female exclusion criteria: 1. Pending court case for IPV or pending child protection hearing

Design outcomes

Primary

Measure	Time frame
This is a feasibility trial. The objectives of the study are to explore the acceptability and feasibility of an intervention to reduce intimate partner violence (IPV) among men in treatment for substance use compared to substance use treatment as usual. The feasibility of recruiting and retaining men in substance use treatment who have perpetrated IPV in the past 12 months and their current and ex female partners to the feasibility trial will be determined. To demonstrate the feasibility: 1. of recruiting and retaining men in substance use treatment who have perpetrated intimate partner violence (IPV) in the past 12 months to a trial comparing a group intervention to treatment as usual (TAU) 2. of delivering the group intervention across three regions in England (London, Wolverhampton and Bristol) 3. of recruiting and retaining current and ex female partners of these men in the trial as collateral informants To evaluate: 1. the level of treatment engagement and retention for men, and explore through focus groups and qualitative interviews their views, acceptability and experiences of the intervention and the study process 2. the level of engagement and retention with women’s support for IPV victimisation for female current and ex-partners, and explore through qualitative interviews their views, acceptability and experiences of women’s support and the study process 3. the views, acceptability and experiences of the facilitators who delivered the intervention 4. the suitability and acceptability of outcome measures	—

Measure

Time frame

This is a feasibility trial. The objectives of the study are to explore the acceptability and feasibility of an intervention to reduce intimate partner violence (IPV) among men in treatment for substance use compared to substance use treatment as usual. The feasibility of recruiting and retaining men in substance use treatment who have perpetrated IPV in the past 12 months and their current and ex female partners to the feasibility trial will be determined. To demonstrate the feasibility: 1. of recruiting and retaining men in substance use treatment who have perpetrated intimate partner violence (IPV) in the past 12 months to a trial comparing a group intervention to treatment as usual (TAU) 2. of delivering the group intervention across three regions in England (London, Wolverhampton and Bristol) 3. of recruiting and retaining current and ex female partners of these men in the trial as collateral informants To evaluate: 1. the level of treatment engagement and retention for men, and explore through focus groups and qualitative interviews their views, acceptability and experiences of the intervention and the study process 2. the level of engagement and retention with women’s support for IPV victimisation for female current and ex-partners, and explore through qualitative interviews their views, acceptability and experiences of women’s support and the study process 3. the views, acceptability and experiences of the facilitators who delivered the intervention 4. the suitability and acceptability of outcome measures

—

Secondary

Measure	Time frame
As a feasibility trial, this study is not powered to determine the effectiveness of the intervention. Outcomes will be assessed at baseline and end of the intervention (14-16 weeks post baseline) for men participating in the trial and their current and ex-partners. The following outcomes will be assessed for both IPV perpetrators and survivors: 1. Depressive symptoms, assessed using PHQ-9 2. Anxiety symptoms, assessed using GAD-7 3. Post-traumatic stress, assessed using Primary Care PTSD Screen 4. Perpetrator and survivor reports of IPV perpetration, assessed using Abusive Behavior Inventory 5. Risk (men only), assessed using Propensity for Abusiveness Scale 6. Substance use, assessed using Treatment Outcomes Profile; Addiction Severity Index 7. Quality of life, assessed using SF-12; EQ-5D-3L 8. Service use 9. Criminal justice involvement Timepoint(s): 16 weeks post-randomisation (+ window of 4 weeks) for male participants in both the intervention and control arms, and their current or ex female partners. The suitability and acceptability of potential outcome measures for use in a future efficacy trial will be considered by exploring: 1. Completeness of data 2. Researchers’ perception of participants’ understanding (e.g. of language and meaning of questions) 3. Researchers’ perception of participants’ acceptability (e.g. if participant refuses to answer or gets annoyed/frustrated or asks to end the interview) Recorded for each outcome measure using a predetermined rating scale. Poor completeness of data and low ratings of researchers’ perceptions of participants’ understanding and acceptability of outcome measures will lead to these outcome measures being considered unsuitable for the future efficacy trial.	—

Measure

Time frame

As a feasibility trial, this study is not powered to determine the effectiveness of the intervention. Outcomes will be assessed at baseline and end of the intervention (14-16 weeks post baseline) for men participating in the trial and their current and ex-partners. The following outcomes will be assessed for both IPV perpetrators and survivors: 1. Depressive symptoms, assessed using PHQ-9 2. Anxiety symptoms, assessed using GAD-7 3. Post-traumatic stress, assessed using Primary Care PTSD Screen 4. Perpetrator and survivor reports of IPV perpetration, assessed using Abusive Behavior Inventory 5. Risk (men only), assessed using Propensity for Abusiveness Scale 6. Substance use, assessed using Treatment Outcomes Profile; Addiction Severity Index 7. Quality of life, assessed using SF-12; EQ-5D-3L 8. Service use 9. Criminal justice involvement Timepoint(s): 16 weeks post-randomisation (+ window of 4 weeks) for male participants in both the intervention and control arms, and their current or ex female partners. The suitability and acceptability of potential outcome measures for use in a future efficacy trial will be considered by exploring: 1. Completeness of data 2. Researchers’ perception of participants’ understanding (e.g. of language and meaning of questions) 3. Researchers’ perception of participants’ acceptability (e.g. if participant refuses to answer or gets annoyed/frustrated or asks to end the interview) Recorded for each outcome measure using a predetermined rating scale. Poor completeness of data and low ratings of researchers’ perceptions of participants’ understanding and acceptability of outcome measures will lead to these outcome measures being considered unsuitable for the future efficacy trial.

—

Countries

England, United Kingdom

Outcome results

None listed